GlassScriptPhysician profile
Arrington Madison
NPI 1194254227
$1,008.33
in general payments reported to CMS, 2019-2025
12 companies · $314 in 2025
The $314 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $181 · 2023: $186 · 2024: $328 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $479.05 | 2023-2025 | Azstarys |
| Organon LLC | $105.28 | 2022 | |
| Glaxosmithkline, LLC. | $61.35 | 2022-2024 | Pediarix, Rotarix, Bexsero |
| Collegium Pharmaceutical, INC. | $59.57 | 2025 | Jornay Pm |
| Pfizer INC. | $55.19 | 2022-2023 | |
| Seqirus USA INC | $49.41 | 2024-2025 | Flucelvax, Fluad |
| Abbvie INC. | $49.25 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $44.65 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $40.68 | 2024 | |
| Supernus Pharmaceuticals, INC. | $37.66 | 2024-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $14.00 | 2024 | Vaqta, Gardasil 9, Gardasil |
| Philips North America LLC | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arrington Madison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.